Resources
Start and stay on therapy
For Novartis Patient Support™ resources, including the Start Form and Prior Authorization Appeals Kit, visit the Novartis Patient Support page.
Resources for your practice
Diagnostic Tool
Help shorten your patients’ path to diagnosis. This resource can be used as a tool to help you recognize and diagnose PNH.
Onboarding Guide
Help your patients along their treatment journey—a guide to resources to help patients start and stay on treatment with FABHALTA.
FABHALTA Electronic Health Record Guides
An EHR considerations checklist for development, configuration, and modification of EHR components that may be relevant to treatment with FABHALTA.
Discover FABHALTA: Patient experiences & data
From “Fine” to FABHALTA: Kim’s PNH Journey
Since her diagnosis, Kim has refused to let PNH define her. In this video, she shares how treatment with FABHALTA has helped her maintain balance in her day-to-day life—and achieve increased hemoglobin levels.*
*Normal Hb levels vary but generally are between 12-16 g/dL for women and 13-18 g/dL for men.
From “Fine” to FABHALTA: Shonda’s PNH Journey
Shonda found stability on a C5i as her Hb reached 10.3 g/dL.† But a switch to FABHALTA took her further, and her Hb increased to 13.5 g/dL‡ without the need for infusion-based therapy. Shonda is sharing her story—and her hope for the future with FABHALTA.
†Based on patient-reported values as of April 2024.
‡Based on patient-reported values as of March 2025.
‡Based on patient-reported values as of March 2025.
Explore the Patient Experience with Kim
Meet Kim, an actual patient with PNH, and learn how discovering FABHALTA with her doctor led to clinical benefits that have positively impacted her treatment journey.
Explore the Patient Experience with Shonda
Introducing Shonda, a patient with PNH who switched from a C5i to FABHALTA, sharing how this switch led to clinical benefits and improved her overall experience in managing the challenges of living with PNH.
APPULSE Data
Explore a different approach with data from a trial that specifically evaluated patients on a stable C5i regimen with ≥10 g/dL who switched to FABHALTA.
Resources for your patients
Hear from real FABHALTA patients and learn about their PNH treatment journeys
Interested in learning more about how FABHALTA may help your adult patients with PNH?